About

Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-acting biologics. Our goal is to bring to patients medicines that will transform their lives.

Management

H. Michael Keyoung
M.D., Ph.D.
President,
Chief Executive Officer
Young Chul Sung
Ph.D.
Chairman,
Chief Technology Officer
You Suk Suh
Ph.D.
Representative Director, R&D
Jae Chan Park
Ph.D.
Executive Vice President,
QA / Alliance Management
Kyudon Kim
Ph.D.
Executive Vice President, COO
Sung Hee Lee
Ph.D.
Executive Vice President,
Head of Bio Research Institute
Jungwon Woo
Ph.D.
Vice President,
Head of Clinical Division
Tae Kim
Ph.D.
Vice President,
Clinical Operation
   Previous Next   
  • H. Michael Keyoung, M.D., Ph.D.
    President, Chief Executive Officer
    H. Michael Keyoung is President and CEO of Genexine Inc. He is also Founding Managing Partner of Portola Capital Partners, a healthcare-dedicated investment firm that invests and advises healthcare companies globally. Dr. Keyoung is physician, investor and entrepreneur with 20 years of experience. Until recently, Dr. Keyoung was President of Catalyst Biosciences. Previously, Dr. Keyoung was Managing Director of US venture capital firm, Burrill & Company. Throughout his career, he has advised leading healthcare companies in their regional expansion to Asia or global drug development, commercial strategies and partnerships. Dr. Keyoung was a Howard Hughes Medical Institute Research fellow and received his clinical surgical training at the University of California, San Francisco. He did his biomedical fellowship at the Memorial Sloan Kettering Institute and at Rockefeller University in New York. Dr. Keyoung received both his M.D. and Ph.D. in Neuroscience and Neurology from Cornell University Weill Medical College and Memorial Sloan Kettering Cancer Center.
  • Young Chul Sung, Ph.D.
    Chairman, Chief Technology Officer
    Young Chul Sung is the founder and former CEO of Genexine. He currently serves as Chief Technology Officer of Genexine. He is also a professor at POSTECH Department of Life Sciences and founder of POSTECH- Catholic Bio Medical Institute. Dr. Sung is an expert immunologist and has published over one hundred scientific articles. He has served on editorial boards of many biological organizations and has earned numerous awards including the most recently the Scientists of the Year 2014 from Korea Science Journalist Association. Dr. Sung received his B.S. from Yonsei University, Ph.D degree from University of Minnesota and postdoctoral training at Harvard University.
  • You Suk Suh, Ph.D.
    Representative Director, R&D
    You Suk Suh has served as Representative Director and Head of R&D since August 2015. Dr. Suh joined Genexine in 2006 and held multiple leadership positions over the years in Genexine, including Head of Bio Efficacy Center before taking his current position. Dr. Suh received his Ph.D. degree from POSTECH (Korea) and postdoctoral training at Deutches Primatenzentrum GmbH (Germany). He worked as research follow at Alexander-von-Humboldt foundation prior to joining Genexine.
  • Jae Chan Park, Ph.D.
    Executive Vice President, QA / Alliance Management
    Jae Chan Park is in charge of Alliance Operation and joined Genexine in January 2015. Prior to joining Genexine, Dr. Park was at Samsung Advanced Institute of Technology (SAIT) in Samsung Electronics for 17 years and held the position of Senior Vice President and Managing Director of Bio R&D Center before his departure from Samsung. Prior to that, he served as Director at Hanhyo Institute of Technology and Senior Research Investigator at G.D. Searle (then Monsanto Pharma). Dr. Park earned his B.S. and M.S. in Chemistry from Seoul National University, Ph.D. from Princeton University and postdoctoral fellowship at Indiana University.
  • Kyu Don Kim,Ph.D.
    Executive Vice President, COO
    Kyudon Kim joined Genexine in December 2015 as Excutive Vice President and he is in charge of Business. Prior to joining Genexine, Dr Kim was at Bio Business Team of New Business Division in Samsung Electronics and held the position of Senior Vice President . Prior to that, he served as Head of Product Development Division in LG Life Sciences Ltd. Dr Kim received his B.S and M.S in Biochemistry from Yonsei University, MBA degree from Sogang University and Ph.D. in Chemistry from University of Northern Illinois.
  • Sung Hee Lee, Ph.D.
    Executive Vice President, Head of Bio Research Institute
    Sung Hee Lee is Executive Vice president and Head of Bio Research Institute and joined Genexine in January 2015. Prior to joining Genexine, Dr. Lee held several senior management positions at Dong-A Socio Holdings, most recently Senior Vice President and Head of Biotech Research Center. He began his pharmaceutical career at Dong-A Pharmaceutical Research Division and spent over thirty years at Dong-A. Dr. Lee held teaching position at Sungkyunkwan University. He earned his B.S., M.S. and Ph.D in Industrial Chemistry from Seoul National University.
  • Jungwon Woo, Ph.D.
    Vice President, Head of Clinical Division
    Jungwon Woo is in charge of Clinical Planning and joined Genexine in 2013. Previously, Dr. Woo was Senior Researcher at Samsung Bio Research Institute and later at Convergent Research Consortium for Immunologic Disease in Seoul St Mary’s Hospital. Dr. Woo received her B.S. and M.S. in Pharmacy from Seoul National University and Ph.D. in Microbiology from Cornell University. She did her postdoctoral fellowship at Harvard Medical School.
  • Tae Kim, Ph.D.
    Vice President, Clinical Operation
    Tae Kim is in charge of Clinical Science & Development and joined Genexine in 2014. Prior to joining Genexine, Dr. Kim held several executive positions and head of medical division for several biotech and pharmaceutical companies. Previously, Dr. Kim was Vice President and Chief of Medical Division at JW Pharmaceutical and Vice President of R&D at Samil Pharmaceutical. Prior to Samil, Dr. Kim was Associate Director in the Department of Clinical Affairs at Qualitest Pharmaceuticals and Principal Scientist at Sandoz and at Banner Pharmacaps. Dr. Kim received his M.S. and Ph.D. in Biochemistry from University of Montpellier I, France and postdoctoral fellowship at University of Connecticut.

Board of Directors

Young Chul Sung, Ph.D.
Founder & Chief Technology Officer,
Genexine and Chairman of the Board of Directors
H. Michael Keyoung, MD., Ph.D.
President & Chief Executive Officer,
Genexine
You Suk Suh, Ph.D.
Representative Director & Head of Research Institute,
Genexine
Young-Jin Kim
Chairman & CEO, Handok
In Jun Song
CEO, IMM Private Equity
Mi-Chung Ahn, Ph.D.
Managing Partner, Eruum Patent Law Firm
Young-Dae Yoon, Ph.D.
Dean and Professor, Ewha University